Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Aug 25;14(17):3492.
doi: 10.3390/nu14173492.

Effects of a Novel Amino Acid Formula on Nutritional and Metabolic Status, Anemia and Myocardial Function in Thrice-Weekly Hemodialysis Patients: Results of a Six-Month Randomized Double-Blind Placebo-Controlled Pilot Study

Stefano Murtas  1 , Roberto Aquilani  2 , Gianmarco Fiori  3 , Roberto Maestri  4 , Paolo Iadarola  5 , Cristina Graccione  1 , Rita Contu  1 , Maria Luisa Deiana  1 , Fabrizio Macis  1 , Romina Secci  1 , Antonella Serra  1 , Mariella Cadeddu  1 , Maura D'Amato  5 , Paola Putzu  1 , Mirella Marongiu  1 , Piergiorgio Bolasco  6
Affiliations
Randomized Controlled Trial

Effects of a Novel Amino Acid Formula on Nutritional and Metabolic Status, Anemia and Myocardial Function in Thrice-Weekly Hemodialysis Patients: Results of a Six-Month Randomized Double-Blind Placebo-Controlled Pilot Study

Stefano Murtas et al. Nutrients. .

Abstract

(1) Background: Chronic Kidney Disease (CKD) induces metabolic derangement of amino acid (AA) kinetics, eliciting severe damage to the protein anabolism. This damage is further intensified by a significant loss of AAs through hemodialysis (HD), affecting all tissues with a high metabolic turnover, such as the myocardium and body muscle mass. (2) Aim: to illustrate the effects of a novel AA mixture in boosting mitochondrial energy production. (3) Methods: A strict selection of 164 dialysis patients was carried out, allowing us to finally identify 22 compliant patients who had not used any form of supplements over the previous year. The study design envisaged a 6-month randomized, double-blind trial for the comparison of two groups of hemodialysis patients: eleven patients (67.2 ± 9.5 years) received the novel AA mix (TRG), whilst the other eleven (68.2 ± 10.5 years) were given a placebo mix that was indistinguishable from the treatment mix (PLG). (4) Results: Despite the 6-month observation period, the following were observed: maintenance of target hemoglobin values with a reduced need for erythropoiesis-stimulating agents in TRG > 36% compared to PLG (p < 0.02), improved phase angle (PhA) accompanied by an increase in muscle mass solely in the TRG group (p < 0.05), improved Left Ventricular Ejection Fraction (LVEF > 67%) in the TRG versus PLG group (p < 0.05) with early but marked signs of improved diastolic function. Increased sensitivity to insulin with greater control of glycemic levels in TRG versus PLG (p = 0.016). (5) Conclusions: the new AA mix seemed to be effective, showing a positive result on nutritional metabolism and cardiac performance, stable hemoglobin levels with the need for lower doses of erythropoietin (EPO), insulin increased cell sensitivity, better muscle metabolism with less loss of mass.

Keywords: amino acid replacement; hemodialysis; hydration; metabolic and nutritional disorders.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Rostoker G., Lepeytre F., Rottembourg J. Inflammation, serum iron, and risk of mortality and cardiovascular events in non dialysis CKD patients. J. Am. Soc. Nephrol. 2022;33:654–655. doi: 10.1681/ASN.2021081044. - DOI - PMC - PubMed
    1. Wang Y., Gao L. Inflammation and cardiovascular disease associated with hemodialysis for end-stage renal disease. Front. Pharmacol. 2022;13:800950. doi: 10.3389/fphar.2022.800950. - DOI - PMC - PubMed
    1. Rosenstein K., Tannock L.R. Dyslipidemia in chronic kidney disease. In: Wilson D.P., editor. Endotext [Internet] MDText.com, Inc.; South Dartmouth, MA, USA: 2022.
    1. Popkov V.A., Zharikova A.A., Demchenko E.A., Andrianova N.V., Zorov D.B., Plotnikov E.Y. Gut microbiota as a source of uremic toxins. Int. J. Mol. Sci. 2022;23:483. doi: 10.3390/ijms23010483. - DOI - PMC - PubMed
    1. Burrowes J.D., Larive B., Chertow G.M., Cockram D.B., Dwyer J.T., Greene T., Kusek J.W., Leung J., Rocco M.V., Hemodialysis (HEMO) Study Group Self-reported appetite, hospitalization and death in haemodialysis patients: Findings from the Hemodialysis (HEMO) Study. Nephrol. Dial. Transplant. 2005;20:2765–2774. doi: 10.1093/ndt/gfi132. - DOI - PubMed

Publication types